HERNANDEZ VAZQUEZ, EDUARDO
CIENCIAS DE LA VIDA · Nivel 2
Medicinal Chemistry
Fab1 inhibitors
Control of virulence factors in bacteria
Multicomponent synthesis of aza-heterocycles
Cannabinoid receptor 1 antagonists
Desde 2020 es en Instituto de Química, UNAM
Información*
| Nombre | EDUARDO HERNANDEZ VAZQUEZ |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | QUÍMICA FARMACÉUTICA |
| Especialidad | DISEÑO, SINTESIS Y ESTUDIO DE NUEVOS FARMACOS |
| CVU | 256691 |
| Institución | |
|---|---|
| Dependencia | COORDINACION DE LA INVESTIGACION CIENTIFICA |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2025 |
| Fin: 31/12/2029 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Últimas publicaciones Scopus
- 2026
- Methoxylated 3,4-diaryl-5-methyl-1(H)-pyrazoles: discovery of a new anti-inflammatory scaffold Bioorganic Chemistry · Vol. 175 Article
- Triazole-containing xanthone-furanose/pyranose hybrids: synthesis of potential α-glucosidase inhibitors European Journal of Medicinal Chemistry · Vol. 302 Article
- Synthesis of 2-(Quinoxalin-2-yl)acetamides and Their Preliminary Cytotoxic and Antibacterial Activity Chemistry and Biodiversity · Vol. 23 Article
- 2025
- Synthesis of Urea-Containing Derivatives and their Application as Potential Anti-Methicillin-Resistant Staphylococcus Aureus Agents Chemmedchem · Vol. 20 Article
- Imide-based enones: A new scaffold that inhibits biofilm formation in Gram-negative pathogens Bioorganic and Medicinal Chemistry Letters · Vol. 122 Article